Register for our free email digests:
Merck KGaA
www.emdgroup.com/en
Latest From Merck KGaA
Decade In Review: C-Suite Shifts At Family-Owned Indian Firms
Scrip traces some of the prominent changes in the corner office at front-line, family-owned Indian firms Cipla and Dr Reddy’s in the decade gone by.
Grooming Investments Pay Off, Merck OTCs Count Organically In P&G's Latest Quarter
P&G’s grooming segment grew 4% in its latest quarter, the third consecutive of organic growth as the Gillette brand wins 18m customers in 12 months. The results suggest investments the company made to ward off subscription-based competitors are starting to pay off.
More Surufatinib Cheer For Chi-Med As Second NET Trial Stopped Early
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.
Asia Deal Watch: BeiGene Gets Chinese Rights To Two EUSA Rare Disease Therapies
BeiGene licenses antibody therapeutics for Castleman’s disease and high-risk neuroblastoma.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Parent & Subsidiaries
-
Merck KGaA
- Amerpharm Investments Ltd.
- Biovation Ltd.
- Center Laboratories
- Chemische Fabrik Lehrte Dr. Andreas Kossel
- Durachemie GMBH
- E. Merck Nederland
- EM Laboratories Inc
- EM Pharmaceuticals Inc.
- EMD Biosciences Inc.
- EMD Chemicals Inc.
- EMD Lexigen Research Center
- EMD Serono Inc.
- Genpharm Inc.
- Hermal Kurt Herrmann & Co.
- Hermal Pharmaceutical Laboratories Inc.
- Laboratoire Theramex
- Laboratoires Merck-Clevenot SA
- Laboratorios BOI SA
- Lipha Chemicals Inc.
- Lipha Pharmaceuticals Inc.
- Lipha SA
- Merck Eprova AG
- Merck Ethicals
- Merck HOEI
- Merck Lipha
- Merck Pharma SPA
- Merck Pty. Ltd.
- Merck SA Industrias Quimicas
- Merck Sante SAS
- Merck Serono SA
- MilliporeSigma
- NM Pharma AS
- Novagen Inc.
- VWR Canlab
- Senior Management
-
Stefan Oschmann, PhD, CEO
Marcus Kuhnert, CFO - Contact Info
-
Merck KGaA
Phone: (49) 6151 72 0
Frankfurter Str. 250
Darmstadt, MA 64293
Germany
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice